(Q43726031)

English

A randomized, controlled trial of a low-dose contraceptive containing 20 microg of ethinyl estradiol and 100 microg of levonorgestrel for acne treatment

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 November 2017

A randomized, controlled trial of a low-dose contraceptive containing 20 microg of ethinyl estradiol and 100 microg of levonorgestrel for acne treatment (English)

1 reference

Europe PubMed Central

26 November 2017

1 reference

based on heuristic

inferred from title

author name string

D Thiboutot

1

1 reference

Europe PubMed Central

26 November 2017

D F Archer

2

1 reference

Europe PubMed Central

26 November 2017

A Lemay

3

1 reference

Europe PubMed Central

26 November 2017

K Washenik

4

1 reference

Europe PubMed Central

26 November 2017

J Roberts

5

1 reference

Europe PubMed Central

26 November 2017

D D Harrison

6

1 reference

Europe PubMed Central

26 November 2017

language of work or name

0 references

publication date

1 September 2001

1 reference

Europe PubMed Central

26 November 2017

Fertility and Sterility

1 reference

Europe PubMed Central

26 November 2017

76

1 reference

Europe PubMed Central

26 November 2017

3

1 reference

Europe PubMed Central

26 November 2017

461-468

1 reference

Europe PubMed Central

26 November 2017

New treatments and therapeutic strategies for acne

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2901938-0

7 January 2021

The evaluation and management of acne: economic considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2901938-0

7 January 2021

Current views on the aetiology, pathogenesis and treatment of acne vulgaris

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2901938-0

7 January 2021

Effect of low-dose oral contraceptives on androgenic markers and acne.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2901938-0

7 January 2021

Changes in androgens during treatment with four low-dose contraceptives.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2901938-0

7 January 2021

Attenuation of mild hyperandrogenic activity in postpubertal acne by a triphasic oral contraceptive containing low doses of ethynyl estradiol and d,l-norgestrel

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2901938-0

7 January 2021

Effects of seven low-dose combined oral contraceptives on sex hormone binding globulin, corticosteroid binding globulin, total and free testosterone

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2901938-0

7 January 2021

Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: a randomized, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2901938-0

7 January 2021

Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2901938-0

7 January 2021

Clinical and hormonal effects of ethinylestradiol combined with gestodene and desogestrel in young women with acne vulgaris.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2901938-0

7 January 2021

A new low-dose monophasic combination oral contraceptive (Alesse) with levonorgestrel 100 micrograms and ethinyl estradiol 20 micrograms. North American Levonorgestrel Study Group (NALSG).

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2901938-0

7 January 2021

Efficacy and safety of a low-dose monophasic combination oral contraceptive containing 100 microg levonorgestrel and 20 microg ethinyl estradiol (Alesse). North american Levonorgestrel Study Group (NALSG).

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2901938-0

7 January 2021

Cycle control with oral contraceptives containing 20 micrograms of ethinyl estradiol. A multicenter, randomized comparison of levonorgestrel/ethinyl estradiol (100 micrograms/20 micrograms) and norethindrone/ethinyl estradiol (1000 micrograms/20 mic

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2901938-0

7 January 2021

A multirater validation study to assess the reliability of acne lesion counting.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2901938-0

7 January 2021

Report of the Consensus Conference on Acne Classification. Washington, D.C., March 24 and 25, 1990.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2901938-0

7 January 2021

The use of oral contraceptives by adolescents for contraception, menstrual cycle problems or acne

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2901938-0

7 January 2021

Use of placebo controls in an oral contraceptive trial: methodological issues and adverse event incidence

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2901938-0

7 January 2021

Clinical usefulness of low-dose oral contraceptives for the treatment of adolescent hyperandrogenemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2901938-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0015-0282(01)01938-0

1 reference

Europe PubMed Central

26 November 2017

1 reference

Europe PubMed Central

26 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43726031&oldid=2102863918"